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Limerick: forever associated with five lines of rhyme or infamous for irrepressible 
carbapenemase-producing Enterobacteriaceae for all time? 
Sir, 
 In the context of January’s edition of this journal, focused on multidrug-resistant 
Gram-negative bacteria (MDRGNB) to coincide with publication of new Joint Working Party 
Recommendations on the prevention and control of MDRGNB, we wish to report the 
increasing prevalence of carbapenemase-producing Enterobacteriaceae (CPE) at our 440-bed 
hospital in Ireland’s mid-west.1,2 
The first reported case of CPE in Ireland was in Limerick in 2009, as was the first 
outbreak of cfr-mediated linezolid-resistant Staphylococcus epidermidis.3,4 We have now 
identified 140 discrete isolates, each pertaining to a single patient, by retrospective audit of 
microbiological analyses performed at University Hospital Limerick between February 2009 
and December 2015. Despite identification of operational factors associated with the 
incidence, and best efforts towards rectifying those, there has been an inexorable increase in 
CPE detection; two were identified in 2009, four in 2010, 11 in 2011, 10 in 2012, eight in 
2013, 45 in 2014, and 60 in 2015. Seasonality is evident with highest numbers detected in the 
spring and summer months.  
Of the associated carbapenemases, one was imipenem, three were oxacillin (OXA), 13 
were New Delhi metallo-β-lactamase (NDM), and 123 were Klebsiella pneumoniae 
carbapenemase (KPC). During this period, two outbreaks occurred. In 2011, three out of nine 
patients affected by KPC-producers died, whereas in 2014 one out of 10 patients affected by 
NDM-producers died. Rectal swabs accounted for 74% (N = 103) of our CPE-positive results 
over this six-year period. This is in contrast to the outcome of an Irish prevalence study 
performed in 2011 across 40 Irish critical care units (37 adult and three paediatric), which 
found no CPE carriage.5 However, as CPE was emerging as a global public health challenge 
at that time, those authors were prescient in recommending the importance of maintaining 
vigilance for CPE in Ireland. 
Our current analysis has identified two fatal KPC bacteraemias, three intra-abdominal 
theatre-derived samples positive for CPE, with K. pneumoniae (N = 80), Klebsiella oxytoca 
(N = 30), and Citrobacter freundii (N = 17) dominant. Indeed, our 2011 outbreak documented 
transmission of these strains between Irish hospitals.6 Subsequent to this outbreak, CPE 
screening has been performed, in accordance with national guidelines, via rectal swab or stool 
specimen, for all patients admitted to our intensive care unit or high dependency unit; 
similarly for any patient transferred from another healthcare institution, any patient who has 
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for paediatric, maternity or orthopaedic care), and for any patient previously hospitalized 
abroad. In total, 2685 screens were processed in 2011, increasing to 6128 in 2014, and 
exceeding 9493 in 2015.  
We have benefited from considerable investment in on-site rapid molecular laboratory 
technology. A dedicated hygiene nurse has been appointed to monitor and audit the quality of 
environmental cleaning. A permanent cohort ward opened in November 2015. Local CPE 
guidelines have been drafted in line with international best practice along with 
implementation of the Public Health England carbapenem-resistant Enterobacteriaceae (CRE) 
toolkit. Hydrogen peroxide vapour decontamination is performed post discharge of any KPC-
colonized or -infected patient. Chlorhexidine gluconate wash-cloths are used to bathe all 
patients in critical care areas, and a recent review of clinical staff has shown 84% hand 
hygiene compliance. Despite these measures, control has proved ineffective. Reliance on 
acute 16-bedded nightingale wards, insufficient isolation rooms, emergency department 
overcrowding, and lack of unique patient identifiers or of an integrated information 
technology system are hindering our efforts to contain CPE.  
Moreover, due to observed seasonality and the prevalence of agriculture in the 
Limerick region, we are exploring a sectoral link to our CPE challenge. Measures have been 
taken in our hospital to limit prescription of carbapenems, thus reducing consumption by 21% 
in 2015 versus increases of 36%, 25%, and 4% in 2012, 2013, and 2014, respectively. 
However, in comparison to the UK, there are few published data in Ireland regarding 
carbapenem consumption in the veterinary industry, whereas previous reports have linked 
NDM-1 and OXA-48 with close proximity to animals.7  
Limerick is known as Ireland’s ‘Treaty City’ due to a Jacobite siege in 1691. We are 
developing a new siege mentality, and we believe that a national strategy for CPE, akin to that 
adopted in Israel, is urgently needed to avoid a country-wide replication of the Limerick CPE 
endemic.8 
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